Pharmally

The Sandiganbayan has barred Pharmally Pharmaceutical executive Mohit Dargani from leaving the Philippines for an 18-day trip abroad. The decision comes as he faces a graft charge linked to P4.1 billion in anomalous transactions during the COVID-19 pandemic. The court found no justifiable reasons for his travel request.